Xandar Kardian, a Toronto-based industry leader in developing radar signal processing technology for presence detection and vital sign monitoring, has formally announced an integrated partnership with Caregility, an enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere. For the first time ever, Xandar Kardian will embed its radar technology into a partner’s existing product line, joining Caregility’s Best in KLAS Caregility Cloud™ virtual care ecosystem to create a solution wholly focused on optimizing acute patient care. Xandar Kardian and Caregility will debut the solution at the upcoming 2023 HIMSS Global Health Conference and Exhibition in Chicago, April 17-21, and attendees can visit the Xandar Kardian team at Booth #6009-82 in the Innovation Hub/Startup Park of the North Building or at Caregility Booth #6815 in McCormick Place’s North Hall to learn more.
Xandar Kardian’s partnership with Caregility, which will begin rolling out across facilities this spring, combines the capabilities of Xandar Kardian’s patient vital sign monitoring technology through radar signal processing with Caregility’s expertise in virtual clinical workflows and patient analysis to optimize remote acute care. The integration will increase capacity for staff to virtually observe and manage higher-acuity patients in a traditional med-surg environment while leveraging a workflow and connectivity they are already familiar with. Most importantly, the innovative solution will empower clinical teams with new ways to deliver care as chronic workforce challenges persist and staff and consumer expectations evolve.
“Our best-in-class radar technology has the ability to completely transform the future of patient monitoring, especially as telehealth and hybrid healthcare models continue to strengthen as paths for patients to receive acute medical attention,” said Sam Yang, CEO and founder of Xandar Kardian. “We take great pride in our technology’s ability to proactively diagnose and mobilize critical medical care, and we couldn’t ask for a better partner than Caregility to enable our radar technology to be implemented on a wider scale.”
Xandar Kardian’s radar-based solutions, which operate without requiring cameras, wearables, or any patient contact whatsoever, can provide critical early deterioration detection in all varieties of healthcare settings, ranging from inpatient facilities to virtual and home-health care. Xandar Kardian’s sensors can measure 6000+ RHR (Resting Heart Rate) & RR (Respiratory Rate) readings a day, as opposed to a traditional hospital setting, where these vital signs are measured manually on a much less frequent basis. The benefit for partners, such as Caregility, is that the AI-driven radar solution offers autonomous continuous patient monitoring “on demand” through Xandar Kardian’s data dashboard, expanding the capability of their devices and differentiating their own products and solutions.
“We are constantly looking for new innovations and best-in-class solutions to add to Caregility Cloud, our virtual care platform, as we strive to empower clinicians to deliver better care,” explained Pete McLain, Chief Strategy Officer at Caregility. “We are excited about Xandar Kardian’s FDA-cleared radar sensing device and believe it will accelerate access to meaningful trends in patient data to support timely clinical actions with care for patients. And patients love it as it is non-invasive, contactless and private.”
Source: Company Press Release
